{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Clene Inc."},"Symbol":{"label":"Symbol","value":"CLNNW"},"Address":{"label":"Address","value":"6550 SOUTH MILLROCK DRIVE,SUITE G50, SALT LAKE CITY, Utah, 84121, United States"},"Phone":{"label":"Phone","value":"+1 801 676-9695"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements)."},"CompanyUrl":{"label":"Company Url","value":"https://www.clene.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Adam Dorfman","title":"Vice President-Quality & Technical Operations"},{"name":"Austin Rynders","title":"Senior Director-Clinical Operations"},{"name":"Benjamin Greenberg","title":"Head-Medical"},{"name":"D. Kyle Pierce","title":"Vice President-Research & Development"},{"name":"Mark G. Mortenson","title":"Chief Science Officer"},{"name":"Robert Dee Etherington","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}